Clinical Trials · NCT07357766
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,400
- Start date
- Jun 2026
- Locations
- 116 sites, 14 countries
- Primary endpoint
- Relative change in body weight